Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Dyne Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 113 | 127 | +14 |
| Shares | 49.7M | 54.6M | +4.91M (+9.9%) |
| Value | $576.2M | $628.7M | +$52.5M (+9.1%) |
New holders (20)
Institutions that held Dyne Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TCG Crossover Management, LLC | 1,650,150 | $19.0M | 3.71% |
| Octagon Capital Advisors LP | 692,945 | $7.98M | 1.15% |
| Nantahala Capital Management, LLC | 178,901 | $2.06M | 0.20% |
| UBS Oconnor LLC | 176,601 | $2.03M | 0.05% |
| Altium Capital Management LP | 155,000 | $1.79M | 1.07% |
| Integral Health Asset Management, LLC | 57,000 | $656.6K | 0.14% |
| New York Life Investment Management LLC | 42,369 | $488.1K | 0.01% |
| CWM Advisors, LLC | 39,722 | $457.6K | 0.06% |
| ExodusPoint Capital Management, LP | 26,012 | $300.0K | 0.00% |
| Squarepoint Ops LLC | 24,362 | $280.6K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 21,010 | $242.0K | 0.00% |
| TD Asset Management Inc | 20,900 | $240.8K | 0.00% |
| Qube Research & Technologies Ltd | 17,726 | $204.2K | 0.00% |
| Ovata Capital Management Ltd | 15,000 | $172.8K | 0.07% |
| Janus Henderson Group PLC | 11,339 | $130.5K | 0.00% |
| XTX Topco Ltd | 10,629 | $122.4K | 0.03% |
| Wells Fargo & Company | 5,847 | $67.4K | 0.00% |
| Allspring Global Investments Holdings, LLC | 4,397 | $50.7K | 0.00% |
| Truvestments Capital LLC | 464 | $5.34K | 0.00% |
| Spire Wealth Management | 400 | $4.61K | 0.00% |
Sold out (6)
Institutions that held Dyne Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Monashee Investment Management LLC | 123,719 | $1.43M |
| Affinity Asset Advisors, LLC | 92,170 | $1.07M |
| Rafferty Asset Management, LLC | 14,191 | $164.5K |
| Dynamic Technology Lab Private Ltd | 12,223 | $142.0K |
| HSBC Holdings PLC | 10,649 | $118.5K |
| Quantbot Technologies LP | 400 | $4.64K |